ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Brooks Laboratories Ltd reported revenue from operations of ₹19.2 Cr (-18.3% YoY) and net profit of ₹67.6 Cr (+745.0% YoY) for Q2 FY27.
Brooks Laboratories will hold a board meeting on 7 November 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. The trading window is closed until 9 November 2026.
Brooks Laboratories Ltd has submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI regulatory requirements.
Brooks Laboratories approved a demerger of its Manufacturing Business into its wholly-owned subsidiary, Abridge Speciality Limited, through a scheme of arrangement.
Brooks Laboratories informed BSE it has no additional material information to disclose regarding the recent price movement. The company attributed the share price and volume changes to purely market-driven factors.